rs370512642
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2
The NM_001458.5(FLNC):c.31G>A(p.Gly11Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000322 in 1,612,554 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G11C) has been classified as Uncertain significance.
Frequency
Consequence
NM_001458.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FLNC | NM_001458.5 | c.31G>A | p.Gly11Ser | missense_variant | 1/48 | ENST00000325888.13 | |
FLNC | NM_001127487.2 | c.31G>A | p.Gly11Ser | missense_variant | 1/47 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FLNC | ENST00000325888.13 | c.31G>A | p.Gly11Ser | missense_variant | 1/48 | 1 | NM_001458.5 | P3 | |
FLNC | ENST00000346177.6 | c.31G>A | p.Gly11Ser | missense_variant | 1/47 | 1 | A1 |
Frequencies
GnomAD3 genomes ? AF: 0.000177 AC: 27AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000571 AC: 14AN: 245298Hom.: 0 AF XY: 0.0000447 AC XY: 6AN XY: 134186
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1460224Hom.: 0 Cov.: 32 AF XY: 0.0000124 AC XY: 9AN XY: 726408
GnomAD4 genome ? AF: 0.000177 AC: 27AN: 152330Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74492
ClinVar
Submissions by phenotype
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 01, 2022 | The p.G11S variant (also known as c.31G>A), located in coding exon 1 of the FLNC gene, results from a G to A substitution at nucleotide position 31. The glycine at codon 11 is replaced by serine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 16, 2020 | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; Reported in ClinVar but additional evidence is not available (ClinVar Variant ID# 539388; Landrum et al., 2016) - |
Myofibrillar myopathy 5;C3279722:Distal myopathy with posterior leg and anterior hand involvement;C4310749:Hypertrophic cardiomyopathy 26;CN239310:Dilated Cardiomyopathy, Dominant Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 25, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at